Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
P 2 (1)

Trial Status

Unknown1
Enrolling By Invitation1
Recruiting1

Clinical Trials (3)

Showing 3 of 3 trials
NCT07284641Phase 2Recruiting

Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)

NCT01346150Unknown

Patients Treated for SCID (1968-Present)

NCT01186913Enrolling By Invitation

Natural History Study of SCID Disorders

Showing all 3 trials

Research Network

Activity Timeline